Hematologic effects of placental pathology on very low birthweight infants born to mothers with preeclampsia. by Zook, MD, Kelly J et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Pediatrics Faculty Papers Department of Pediatrics
1-1-2009
Hematologic effects of placental pathology on very
low birthweight infants born to mothers with
preeclampsia.
Kelly J. Zook, MD
Thomas Jefferson University
Amy B. Mackley, RNC
Christiana Care Health System
Jennifer Kern
Christiana Care Health System
David A. Paul. MD
Thomas Jefferson University, DPaul@Christianacare.org
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/pedsfp
Part of the Bioethics and Medical Ethics Commons, and the Pediatrics Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Pediatrics Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Zook, MD, Kelly J.; Mackley, RNC, Amy B.; Kern, Jennifer; and Paul. MD, David A., "Hematologic
effects of placental pathology on very low birthweight infants born to mothers with preeclampsia."
(2009). Department of Pediatrics Faculty Papers. Paper 18.
http://jdc.jefferson.edu/pedsfp/18
  
As submitted to: 
 
Journal of Perinatology 
 
And later published as: 
 
“Hematologic effects of placental pathology on very low 
birthweight infants born to mothers with preeclampsia” 
 
Journal of Perinatology 
 
Volume 29, Issue 1, 2009, Pages 8-12 
 
DOI: 10.1038/jp.2008.104 
PubMed ID: 19092839 
 
 
 
Hematologic Effects of Placental Pathology on Very Low Birthweight (VLBW) Infants Born to 
Mothers with Preeclampsia 
 
 
Kelly J. Zook MD1,2, Amy B. Mackley, RNC1, Jennifer Kern1, David A. Paul MD1,2 
 
 
 
1. Department of Pediatrics, Section of Neonatology, Christiana Care Health System, Newark, DE 
 
2. Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA 
 
 
 
 
Running Title: Placental  Effects in Preeclampsia  
 
 
 
 
Corresponding Author: 
Kelly Zook, MD 
Christiana Care Health System 
Department of Neonatology 
4755 Ogletown-Stanton Road 
Newark, DE 19718 
(302) 733-2410 
Fax: (302) 733-2602 
Email: Kelly.zook@mail.tju.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Condensation 
 
 
 
Infants born to mothers with preeclampsia who had neutropenia and thrombocytopenia did not have an 
increased occurrence of placental infarction or maternal vasculopathy but were more likely to be small for 
gestational age (SGA) and of lower gestational age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 
 
Objective:  To investigate the effect of placental pathology on neonatal white blood cells (wbc), platelets 
(plt), hematocrit (hct) and nucleated red blood cells (nrbc) in very low birthweight (VLBW) infants born to 
mothers with preeclampsia.  
Study Design:  Retrospective cohort study of infants with birthweight <1500g born to mothers with 
preeclampsia from 7/2002-7/2006 at a single level 3 NICU. Placental pathology was reviewed for presence 
placental infarction and vasculopathy. Hematologic parameters from day of life 0, 1, and 2 were obtained. 
Statistical analysis included repeated measures ANOVA and multivariable analysis using logistic 
regression.  
Results:  The study sample included 203 infants with EGA of 28 ± 3 weeks; 45% had placental infarctions 
and 26% placental vasculopathy. Infants with neutropenia and thrombocytopenia did not have an increased 
occurrence of placental infarction or maternal vasculopathy but were more likely to be SGA and of lower 
gestational age compared to infants without neutropenia or thrombocytopenia. After multivariable analysis, 
gestational age and SGA remained associated with both neutropenia and thrombocytopenia while placental 
infarction and vasculopathy did not remain in the models.  
Conclusions:  In our population of VLBW infants born to mothers with preeclampsia, placental pathology 
was common. There was no association of placental infarction or vasculopathy with neonatal neutropenia, 
thrombocytopenia. The data suggest that neonatal hematologic effects of maternal preeclampsia, if related 
to placental insufficiency, are associated with factors other than placental histology. 
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Introduction 
Preeclampsia is a common disorder of pregnancy affecting nearly 5-8% of pregnant women annually in the 
United States.  The NIH reported in the year 2000 that preeclampsia had risen by one-third over the 
previous decade1.  Preeclampsia is known to be a common cause of neonatal neutropenia and 
thrombocytopenia. It has previously been postulated that both neonatal neutropenia and thrombocytopenia 
result from decreased production of white blood cells and platelets from placental insufficiency 2-9.      
 
Preeclampsia is also known to have associated placental pathology 10.  Different placental histopathologies 
are associated with specific clinical features of preterm preeclampsia.  Severe maternal proteinuria is 
related to placental chronic inflammation, while lower maternal antepartum platelet counts are related to 
placental abruption and infarction. Lower birthweight percentiles and lighter placentas are directly 
associated with uteroplacental vascular lesions 11.   
 
To date, the link between different placental pathological conditions associated with preeclampsia and 
neonatal neutropenia and thrombocytopenia have not been explored.  In this study, we hypothesized that 
there would be specific placental findings associated with neonatal hematologic abnormalities in infants 
born to mothers with preeclampsia. 
 
The purpose of this study was to investigate the association between placental pathology and neonatal 
white blood cells (wbc), platelets (plt), hematocrit (hct) and nucleated red blood cells (nrbc) in VLBW 
infants born to mothers with preeclampsia. 
 
 
 
 
 
 
 
Methods 
The study was a retrospective nested-cohort study of VLBW infants (<1500gm) born to mothers with 
preeclampsia at Christiana Care Health System. Christiana Care Health System is the single level 3 
regional NICU serving the state of Delaware.  The study sample included inborn infants cared for between 
July 2002 and July 2006.  The study sample included only infants born to mothers with preeclampsia.   
 
The diagnosis of preeclampsia was made by the attending obstetrician based on ACOG guidelines of 
elevated blood pressure (>140 systolic or >90 diastolic) and proteinuria (>0.3gm of protein in a 24 hour 
urine collection) after 20 weeks of gestation 12.  For the purposes of this study, estimated gestational age 
(EGA) was defined by best obstetric estimate.  Small for gestational age (SGA) was defined as birth weight 
<10%. Data on prenatal steroid administration was collected and mothers were classified as receiving 
antenatal steroids if they received a minimum of 1 dose of betamethasone or dexamethasone prior to 
delivery.  
 Clinical pathology reports were obtained on all infants. The decision to send the placenta for pathologic 
evaluation was made by the attending obstetrician. The placentas were examined by one of nine attending 
pathologists at Christiana Health Care System who were blinded to the clinical and hematologic outcomes 
of the infants.  The placentas were systematically reviewed according to the Placental Pathology Practice 
Guideline Development Task Force 13.  The reports were reviewed for placental abnormalities using 
standard definitions for commonly described placental lesions 14.  All the infants included in this study had 
placental reports.  Those born to mothers with preeclampsia who did not have a placental pathology report 
were excluded from this study.  
  
Infants in the study sample had complete blood counts (cbc) drawn as per NICU protocol. This included a 
cbc on admission and the 1st two days of life. Cbc’s were obtained more frequently as clinically indicated. 
Hematologic parameters investigated included total white blood cell count, platelet count, hematocrit, and 
total nucleated red blood cells. All cbc’s were analyzed in standard fashion using a Coulter Counter 
(Hialiah, FL). Total nucleated red blood cells were calculated by multiplying the total WBC count by the 
number of NRBC counted per 100 WBC.  . 
 
Thrombocytopenia was defined as platelet count less than 100K/mm3 15. Neutropenia was defined by 
Mouzhino criteria: absolute neutrophil count (ANC) less than 500 on day of life 0, ANC less than 2000 on 
day of life 1, and ANC less than 1100 on day of life 2 16. 
 
 
 
Statistics 
Statistical analysis included both univariable and multivariable analysis. Univariable analysis included Chi 
Square, Mann-Whitney U test, ANOVA, and repeated measures ANOVA as appropriate. Multivariable 
analysis includes Logistic Regression. A p value <.05 was considered significant; all data are expressed as 
mean ± SD.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Results 
During the study period, 211inborn infants were born to mothers with preeclampsia.  The final study 
sample included 203 infants; 8 infants born to mother with preeclampsia were excluded as they did not 
have placental pathology results. In the study sample, 30 infants were diagnosed with neutropenia and 48 
infants with thrombocytopenia during the 1st 48 hours of life.  The distribution of the placental pathologies 
included: infarction (45%), maternal vasculopathy (26%), meconium staining (16%), histologic 
chorioamnionitis (13%), calcification (9%) and funisitis (3%).  Due to their prevalence, placental 
infarction, maternal vasculopathy and placental calcifications were chosen to compare to the presence or 
absence of neutropenia and thrombocytopenia, total nucleated red blood cells and hematocrit values.  
Histologic chorioamnionitis was not considered in relationship to neonatal parameters as it was uncommon 
and likely not related to maternal preeclampsia but rather other co-morbid factors. 
 
 
Infants with neutropenia were of lower gestation, lower birth weight and more likely to be SGA compared 
to the infants without neutropenia (Table 1). There were no differences in the occurrence of placental 
infarction, placental vasculopathy or placental weight in the infants with neutropenia compared to those 
without neutropenia.  After multivariable analysis to control for potential confounding variables including: 
gestational age, birthweight, race, SGA, multiple gestation, use of prenatal steroids, and placental 
pathology, only gestational age (odds ratio of 1.3, 95% confidence 1.1-1.6) and SGA (odds ratio of 4.2 (CI 
1.3-13.5) remained associated with neutropenia.  Neither placental weight nor the presence of placental 
infarction, calcification or vasculopathy was associated with neonatal neutropenia.  
 
Similarly, infants with thrombocytopenia were also found to be of lower gestational age, birth weight and 
more likely to be SGA.  Again, there were no differences found in the occurrence of placental infarction, 
placental vasculopathy, calcification, or placental weight when compared to the infants without 
thrombocytopenia (Table 2).  After multivariable analysis to control for potential confounding variables 
including: gestational age, birthweight, SGA, multiple gestation, use of prenatal steroids and placental 
pathology, only gestational age (OR 1.2 , 95% CI 1.0-1.4) and SGA (OR 4.2, CI 1.6-11) were associated 
with an increased odds of thrombocytopenia. Neither placental weight nor the presence of placental 
infarction, calcification, or vasculopathy was associated with neonatal neutropenia.   
 
 No association was found between the presence of placental infarction, placental calcification or placental 
vasculopathies and hematocrit or nucleated red blood cells in the first 48 hours of life (data not shown).   
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Discussion 
In our population of VLBW infants born to mothers with preeclampsia, placental pathology was common. 
Despite the common occurrence of placental infarction and maternal vasculopathy, these findings were not 
associated with neonatal neutropenia or thrombocytopenia.  After controlling for potential confounding 
variables lower birthweight, lower gestational age, and/or SGA remained associated with an increased odds 
of neonatal thrombocytopenia and neutropenia. 
 
Preeclampsia continues to be an increasing problem associated with preterm birth and is known to be a 
common cause of neonatal neutropenia and thrombocytopenia 1. The incidence of neutropenia is reported 
as high as 49% in pregnancy induced hypertension exposed infants 2.  Consistent with our findings, 
neutropenia severity has been correlated with the severity of growth restriction and prematurity 4.  Kinetic 
investigations have suggested that neutropenia in infants born to mothers with preeclampsia is secondary to 
decreased production of white blood cells as evidenced by decreased circulating, marginated, storage, 
progenitor and proliferative neutrophils 2.  Our data suggest that the decreased production of white blood 
cells is not associated with histologic changes in the placenta including placental infarction or 
vasculopathy.  
 
Early onset neonatal thrombocytopenia is most commonly observed secondary to placental insufficiency 
with maternal hypertension being the biggest risk factor 17.  Burrows and colleagues  found that in 
hypertensive mothers, preterm birth was the major risk factor for neonatal thrombocytopenia.  Term infants 
exposed to maternal hypertension had the same incidence of thrombocytopenia as the control population 5.  
This finding suggests that hypertension effects may be of a different pathophysiologic pathway in term 
versus preterm infants. This observation is consistent with our finding of thrombocytopenia associated with 
lower gestational age in infants born to mothers with preeclampsia.  
 
Preelcampsia is known to have associated placental pathology. Redline et al evaluated 609 placentas and 
found most placental lesions prior to 37 weeks gestation, specifically maternal vasculopathy, villitis and 
increased intervillous fibrin were increased in pregnancies complicated by hypertension 18.  Soma et al 
described that there are many microscopic findings common in the placentas of hypertensive patients.  
These lesions included increased syncytial knots, villi hypovascularity, cytotrophoblastic proliferation, with 
thickened basement membranes, atherosis of the spiral arteries and narrowed fetal capillaries 10.   Different 
placental histopathologies have been associated with specific clinical features of preterm preeclampsia.  
Severe maternal proteinuria has been related to placental chronic inflammation, while lower maternal 
antepartum platelet counts were related to placental abruption and infarction. In addition, lower birthweight 
percentiles and lighter placentas were directly associated to uteroplacental vascular lesions 19.  Ghidini’s 
prospective study used a scoring system based on severity and extent of placental vascular and villous 
lesions and found that the clinical diagnosis of preeclampsia increased with progressive uteroplacental 
impairment 11.  The lesions defined in Ghidini’s study were analyzed for more specific lesions than is 
typically found in a standard placental pathology report and could not be applied to this study. 
 
We were unable to show any association between placental pathology and neonatal hematologic 
abnormalities. There are a number of potential explanations for this finding and our data should be 
interpreted with caution. There may be no causal effect of placental pathology on neonatal neutropenia or 
thrombocytopenia. Alternatively, placental pathology may still be associated with the hematologic effects 
of maternal preeclampsia, however the placental pathologies leading to neutropenia or thrombocytopenia 
may be different than those selected in this study.  As our investigation was retrospective, we may have 
missed some frequent subtle placental pathologies which may not have been routinely reported on clinical 
pathology reports.  Findings such as increased amounts of syncytial knots and necrosis, thickened 
trophoblastic basement membranes, and narrowed fetal capillaries as previously discussed findings in 
preeclamptic placentas tend to be subtle variations that are not typically commented upon in a routine 
placental pathology analysis.  In addition, some frequent findings in preeclampsia, such as meconium 
staining may be too nonspecific to draw reliable conclusions from.  It may be of benefit to form a 
prospective study designed to have evaluations for specific placental lesions and then analyze if these 
lesions have direct hematologic correlation. 
 
It is plausible that the placental pathologies we investigated were not necessarily associated with 
physiologic placental insufficiency. Perhaps other placental factors may be the causative agents of neonatal 
hematologic aberrations.  Histologic chorioamnionitis, common in preterm birth, has been associated with 
increased levels of cord blood cytokines and increase intracranial hemorrhage in neonates 20-21.  
Inflammation may have a contributing role and warrant further investigation in regards to preeclampsia and 
neonatal neutropenia and thrombocytopenia. The number of infants born to mothers with histologic 
chorioamnionitis in our study cohort was too small to make a meaningful association in our study.  
Furthermore, histologic chorioamnionitis may have been associated with other co-morbidities such as 
premature labor. Other limitations of our study may include the possibility of inter-observer variance and 
lack of consensus on the diagnosis of placental lesions.  However, adhering to methodical practice 
guidelines at a single institution and standard definitions likely limited this variablity. 
 
 
In conclusion, in our population of VLBW infants born to mothers with preeclampsia, placental pathology 
was common.  There was however no association of placental infarction or vasculopathy with neonatal 
neutropenia, thrombocytopenia, or other hematologic parameters.  Our data suggests that the neonatal 
hematologic effects of maternal preeclampsia, if related to placental insufficiency, are associated with 
factors other than placental histology. 
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Table 1: Univariate Analysis of Neutropenia and Placental Pathologies, EGA, BW, Race, SGA, Multiple 
Gestation, Prenatal Steroids 
  Neutropenia present, 
n=30 
Neutropenia absent, 
n=173 
p  
EGA (weeks) 27.9 ± 2.1 29.3 ± 2.4 .02 
BW (grams) 852 ± 283 1091 ±267 <.01 
Placental Infarction 33% 46% .20 
Placental Calcification 10% 9% .85 
Maternal Vasculopathy 33% 25% .41 
Placental Weight 
(grams) 
217 ± 37 245 ± 85 .17 
Race  
(Caucasian/African 
American) 
31%/68% 50%/40% .02 
SGA 37% 15% .01 
Multiple Gestation 17% 16% .93 
Antenatal Steroids 83% 82% .9 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Univariate Analysis of Thrombocytopenia and Placental Pathologies, EGA, BW, Race, SGA, 
Multiple Gestation, Prenatal Steroids 
  Thrombocytopenia 
present, n=48 
Thrombocytopenia 
absent, n=155 
p value 
EGA 28.3 ± 3 29.2 ± 2.3 .04 
BW 882 ± 327 1073 ± 253 <.01 
Placental Infarction 50% 44% .47 
Placental Calcification 10% 8% .80 
Maternal 
Vasculopathy 
25% 28% .73 
Placental Weight 
(grams) 
231 ± 130 223 ± 70 .87 
Race 
(Caucasian/African 
American)  
37%/50% 54%/41% .06 
SGA 43% 17% <.01 
Multiple Gestation 14% 18% .53 
Steroids 68% 69% .84 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
